Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Radiation Oncology
•
Genitourinary Cancers
•
Dermatology
Do you adjust PSA for finasteride use when determining prostate cancer stage and risk category?
If this upstages the patient, do you modify treatment recommendations?
Answer from: Radiation Oncologist at Community Practice
We generally use the rule of 50% (real PSA is twice the lab value when on Finasteride).
Sign in or Register to read more
7534
Related Questions
Do you use Enterade in your patients receiving pelvic RT?
How do you counsel NCCN low and very low risk prostate cancer patients who receive a high risk DECIPHER score?
Would you offer pelvic nodal RT due to failure after previous pelvic node SBRT in oligorecurrent prostate cancer?
How would you manage oligometastatic progression of prostate adenocarcinoma after initial cryotherapy without any upfront XRT?
Would you consider maintenance immunotherapy after cisplatin-gemcitabine chemotherapy and chemoRT for stage 3 bladder cancer in a patient declining cystectomy or who is a poor surgical candidate?
Would you consider pelvic radiation in a patient with prostate cancer and myelofibrosis with mild cytopenias?
Would you offer prostate SBRT to a patient on a TKI?
Does the presence of ductal adenocarcinoma change how you risk stratify or treat patients with localized prostate cancer?
If a patient is noted to have multiple PIRADS-4 and PIRAD-5 lesions of the prostate on MRI, do you offer simultaneous integrated boost via FLAME?
When do you consider elective pelvic nodal irradiation for unfavorable intermediate risk prostate cancer?